comparemela.com

Latest Breaking News On - Liso cel - Page 1 : comparemela.com

Liso-Cel Demonstrates Durable Efficacy in Relapsed/Refractory CLL/SLL

Lisocabtagene maraleucel elicited durable responses in patients with relapsed/refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.

Niravn shahCollege of wisconsinCellular therapy meetingsMedical collegeLiso celIsocabtagene maraleucel liso cel breyanziPhase 1 2 transcend cll 004 trial nct03331198

Current Treatment Options in Third-line MCL

Experts on mantle cell lymphoma discuss third-line treatment options available for patients.

Recent updatesFollicular lymphomaMantle cell lymphomaTreatment optionsThird lineThird line mclCart cellsZuma 2Brexu celZuma 2 trialHigh risk patientsOverall survivalLiso celCart cell therapy

Sequencing Therapies in the Third-Line and Beyond Setting for MCL

A panel of experts discuss how to sequence BTK inhibitors and CAR T-cell therapies in patients with MCL.

Recent updatesFollicular lymphomaMantle cell lymphomaBeyond settingSequencing therapyBrexu celBtk inhibitorCart cell therapyLiso cel

Choosing CAR T-cells as Third-line and Beyond Therapy for FL

Jennifer Crombie, MD, discusses how to choose CAR T-cells as third-line and beyond therapy for FL.

Jennifer crombieRecent updatesFollicular lymphomaMantle cell lymphomaBeyond therapyCart cell therapyHead to trialAxi celTisa celGrade 3 crsLiso celTranscend flTranscend fl trial

ASH Abstracts Showcase Effective Treatments for MM, CLL, FL

Abstracts from the 65th American Society of Hematology (ASH) Annual Meeting and Exposition provided new insight into multiple treatments for patients with multiple myeloma (MM), chronic lymphocytic leukemia (CLL), and follicular lymphoma (FL).

United statesRocky mountainSan diegoLucio gordanTanya siddiqiIanw flinnLucion gordanTycelj phillipsDavidj andorskyGilles sallesDivision of lymphomaDepartment of hematology hematopoietic cell transplantationFlorida cancer specialists research instituteAmerican society of hematologyMountain cancer centersEuropean medicines agency

vimarsana © 2020. All Rights Reserved.